Association of glucagon-like peptide-1 receptor agonist use with anxiety disorders, depression, self-harm, and suicidality: a large cohort study.
Saved in:
| Title: | Association of glucagon-like peptide-1 receptor agonist use with anxiety disorders, depression, self-harm, and suicidality: a large cohort study. |
|---|---|
| Authors: | Anagnostakis F; Centre for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA, USA; Department of Medical and Surgical Sciences, Alma Mater University of Bologna, Bologna, Italy., Kokkorakis M; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Anastasiou G; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece., Nagarajan S; Department of Biomedical Sciences, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA., Mantzoros CS; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Section of Endocrinology, Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA. Electronic address: cmantzor@bidmc.harvard.edu. |
| Source: | Diabetes research and clinical practice [Diabetes Res Clin Pract] 2026 Mar; Vol. 233, pp. 113104. Date of Electronic Publication: 2026 Jan 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8227 (Electronic) Linking ISSN: 01688227 NLM ISO Abbreviation: Diabetes Res Clin Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
